Clinical Trial Update: CNTF Implants for CNGB3 Achromatopsia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating CNTF implants for CNGB3-related achromatopsia has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achromatopsia

Drugs mentioned

• CNTF implant (ciliary neurotrophic factor implant)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Eye Disease, Achromatopsia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-02-25